Understanding the formation mechanism of lipid nanoparticles in microfluidic devices with chaotic micromixers.

about

Understanding the formation mechanism of lipid nanoparticles in microfluidic devices with chaotic micromixers.

Item

http://www.wikidata.org/entity/Q47111806

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Understanding the formation me ...... ices with chaotic micromixers.

@en

Understanding the formation me ...... ices with chaotic micromixers.

@nl

type

Item

label

Understanding the formation me ...... ices with chaotic micromixers.

@en

Understanding the formation me ...... ices with chaotic micromixers.

@nl

prefLabel

Understanding the formation me ...... ices with chaotic micromixers.

@en

Understanding the formation me ...... ices with chaotic micromixers.

@nl

P1476

Understanding the formation me ...... vices with chaotic micromixers

@en

P2093

Akihiko Ishida

http://www.w3.org/2001/XMLSchema#string

Hideyoshi Harashima

http://www.w3.org/2001/XMLSchema#string

Noritada Kaji

http://www.w3.org/2001/XMLSchema#string

Takao Yasui

http://www.w3.org/2001/XMLSchema#string

Yoshinobu Baba

http://www.w3.org/2001/XMLSchema#string

Yuka Fujishima

http://www.w3.org/2001/XMLSchema#string

Yusuke Sato

http://www.w3.org/2001/XMLSchema#string

P2860

Targeted therapy using nanotechnology: focus on cancer

Cancer nanomedicine: from targeted delivery to combination therapy

Developing a highly stable PLGA-mPEG nanoparticle loaded with cisplatin for chemotherapy of ovarian cancer

Rapid microfluidic mixing.

Reduced cardiotoxicity and preserved antitumor efficacy of liposome-encapsulated doxorubicin and cyclophosphamide compared with conventional doxorubicin and cyclophosphamide in a randomized, multicenter trial of metastatic breast cancer.

Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivo

Degradable lipid nanoparticles with predictable in vivo siRNA delivery activity.

Lipid nanoparticle siRNA treatment of Ebola-virus-Makona-infected nonhuman primates.

HDL surface lipids mediate CETP binding as revealed by electron microscopy and molecular dynamics simulation.

Nanoparticle delivery of a peptide targeting EGFR signaling

P304

e0187962

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0187962

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Manabu Tokeshi

Hirofumi Tani

Masatoshi Maeki

P577

2017-11-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29182626

http://www.w3.org/2001/XMLSchema#string

P921

microfluidics

nanoparticle

P932

5705116

http://www.w3.org/2001/XMLSchema#string